Navigation Links
Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations
Date:5/15/2008

rtan component may occur after initiation of treatment with AZOR. Treatment should start under close medical supervision.

Vasodilation

Since the vasodilation attributable to amlodipine in AZOR is gradual in onset, acute hypotension has rarely been reported after oral administration. Nonetheless, caution, as with any other peripheral vasodilator, should be exercised when administering AZOR, particularly in patients with severe aortic stenosis.

Severe Obstructive Coronary Artery Disease

Patients, particularly those with severe obstructive coronary artery disease, may develop increased frequency, duration, or severity of angina or acute myocardial infarction on starting calcium channel blocker therapy or at the time of dosage increase.

Congestive Heart Failure

In general, calcium channel blockers should be used with caution in patients with heart failure.

Impaired Renal Function

In studies of ACE inhibitors in patients with unilateral or bilateral renal artery stenosis, increases in serum creatinine or blood urea nitrogen (BUN) have been reported. There has been no long-term use of olmesartan medoxomil in patients with unilateral or bilateral renal artery stenosis, but similar effects would be expected with AZOR because of the olmesartan medoxomil component.

Hepatic Impairment

Since amlodipine is extensively metabolized by the liver and the plasma elimination half-life (t1/2) is 56 hours in patients with severely impaired hepatic function, caution should be exercised when administering AZOR to patients with severe hepatic impairment.

Laboratory Tests

There was a greater decrease in hemoglobin and hematocrit in the combination product compared to either component alone.

Adverse Reactions

The only adverse reaction that occurred in greater than or equal to 3% of patients treated with AZOR and more frequently than placebo was edema. The placebo-subtracted incidence was 5.7% (5
'/>"/>

SOURCE Daiichi Sankyo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
2. Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95% and Halts Metastasis in a Model of Hormone-Refractory Prostate Cancer
3. CV Therapeutics Anti-Ischemic Therapy Ranexa(R) Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN-TIMI 36 Patients With Angina
4. Recent Studies Suggest Popular Diet Pill Relacore Reduces Acne Breakouts
5. Minimally Invasive Treatment Reduces Shoulder Pain From Tendonitis
6. Smokefree Workplace Law Reduces Heart Attacks 59% Among Nonsmokers, New Research Shows
7. CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year
8. CV Therapeutics Anti-Ischemic Agent Ranexa(R) Significantly Reduces HbA1c and Other Markers of Diabetes in MERLIN TIMI-36
9. VIA Pharmaceuticals Presents Data at American Heart Association Meeting Showing VIA-2291 Significantly Reduces Inflammation in Preclinical Model of Atherosclerosis
10. Study Finds Starion Instruments Tissue Welding Technology Reduces Pain and Bleeding in Tonsillectomy Patients
11. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... 14 Transcept Pharmaceuticals, Inc. (Nasdaq: ... a Notice of Allowance from the United States ... U.S. patent application no. 11/060,641, which covers the ... tartrate sublingual tablet), the lead Transcept product candidate. ... earlier than February 2025. ,, "This is the ...
(Date:12/14/2009)... In response to an FDA notice ... Agency recommended that healthcare facilities discontinue use of ... hospitals throughout the U.S. are faced with the ... According to the FDA, STERIS made changes to ... the safety or the effectiveness of the system ...
(Date:12/14/2009)... -- The board of directors of Eli Lilly and ... dividend for the first quarter of 2010 of $0.49 ... The dividend is payable March 10, 2010 to shareholders ... ,, February 12, 2010. ,, Lilly, a leading innovation-driven ... by applying the latest research from its own worldwide ...
Breaking Medicine Technology:Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo(R) 2Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo(R) 3Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo(R) 4ECRI Institute Issues Steris System 1 High Priority Alert and Recommendations: Free Guidance to Help Hospitals Map out Transition to Alternative Reprocessing Methods 2ECRI Institute Issues Steris System 1 High Priority Alert and Recommendations: Free Guidance to Help Hospitals Map out Transition to Alternative Reprocessing Methods 3Excellence in Paediatrics conference line up includes WHO and CDC pandemic speakers 10130 1Excellence in Paediatrics conference line up includes WHO and CDC pandemic speakers 10130 2Gerton Lab determines the composition of centromeric chromatin 10126 1Gerton Lab determines the composition of centromeric chromatin 10126 2Sogeti USA Grows to Ensure Industry Expertise for Clients 58394 1Sogeti USA Grows to Ensure Industry Expertise for Clients 58394 2Sogeti USA Grows to Ensure Industry Expertise for Clients 58394 3
... – June 25 – MediQuest Therapeutics,Inc., a ... inflammatory and infectious diseases, today announced,the completion ... Vascana,– a topical formulation designed to treat ... end point and demonstrated statistical,significance, with p ...
... Company updates progress and upcoming,milestones on its ... /PRNewswire-FirstCall/ - SemBioSys,Genetics Inc. , a biotechnology ... metabolic and cardiovascular disease,today announced positive preclinical ... insulin. The Company,presented its findings at the ...
Other Medicine Technology:MediQuest Concludes Confirmatory Phase III Study of Raynaud’s,Therapy 2SemBioSys Presents Positive Insulin Data at the American Diabetes,Association Conference 2SemBioSys Presents Positive Insulin Data at the American Diabetes,Association Conference 3SemBioSys Presents Positive Insulin Data at the American Diabetes,Association Conference 4
(Date:12/14/2009)... up 900-Member Physician Staff , ... La Jolla, Calif. ... elected Marc Sedwitz, MD, as the new chief of staff of ... the 900-member physician team on Jan. 1, 2010. , , , ... staff liaison to Scripps La Jolla’s administrative staff and its board ...
(Date:12/14/2009)... Tens of Thousands of New Chronic Hepatitis Infections ... Legislation approved by Congress providing for federal funding ... to reduce tens of thousands of new viral ... States, the National Viral Hepatitis Roundtable ... in the FY 2010 Consolidated Appropriations bill approved ...
(Date:12/14/2009)... BOSTON, Dec. 14 When Kurth Krause, ... crew instructions for landing on the moon, he,was ... about anything.,Years later, Kurth realized there was one ... a kidney transplant and even though dialysis machines,would ... without a transplant. Kurth,wrote: "My wife is 69 ...
(Date:12/14/2009)... some protection, study finds, , , MONDAY, Dec. 14 (HealthDay ... start their morning without a cup or two of ... of developing type 2 diabetes. , That,s the ... more coffee you drink, the lower your risk of ... 7 percent reduction in the risk of diabetes, the ...
(Date:12/14/2009)... might lead to better treatments for asthma, COPD, researchers ... have identified five genetic variants that influence lung function, ... for lung diseases. , The international team of researchers ... the 2.5 million sites across the human genome in ... the team to the five common genetic variants associated ...
Breaking Medicine News(10 mins):Health News:New Chief of Staff Takes Over at Scripps Memorial Hospital La Jolla 2Health News:New Chief of Staff Takes Over at Scripps Memorial Hospital La Jolla 3Health News:NVHR Applauds Congressional Action to End Federal Ban on Funding Syringe Exchange 2Health News:69-Year-Old Grandmother Needing A Lifesaving Kidney Transplant Finds a Miracle on the Internet: a 25-Year-Old Living Altruistic Organ Donor Stranger 2Health News:69-Year-Old Grandmother Needing A Lifesaving Kidney Transplant Finds a Miracle on the Internet: a 25-Year-Old Living Altruistic Organ Donor Stranger 3Health News:Coffee, Tea Might Stave Off Diabetes 2Health News:Coffee, Tea Might Stave Off Diabetes 3
... and warning alerts via Drugs.com and Google Health , ... 24 Drugs.com, the leading online resource for information ... the launch of a new online tool that will ... own medications, to ultimately help reduce dangerous side effects ...
... Forecaster, Medicare shoppers can compare and enroll in many ... NEW YORK, Nov. 24 The day after ... shopping rush. For seniors and their families who need ... to "shop" for coverage using the award-winning bWell-informed(TM) Health ...
... Florida’s Natural Growers was held at the Lake ... November. The theme of this year’s meeting, “Growing ... Cooperative reported one of the highest Orange Returns ... environment. In fact, Chairman Dick Fort stated, “When ...
... Arlene Bardeguez, MD, MPH: , The majority of the one ... or rely on public programs for care. As the ... strain on publicly funded programs will only grow. ... yet know they are infected. Most won,t be diagnosed until ...
... (NYSE: CVD ) is pleased to invite you to listen to its ... 18, 2008 at 9:00 a.m. ET. , , , ... Webcast and slide presentation, When: ... http://www.covance.com , , , Covance, with ...
... low self-esteem, poor relationships with parents, and low academic achievement ... young people having sex before the age of 15. Alternatively, ... reduce risky sexual behavior during adolescence, according to Myeshia Price ... the USA. Their findings have just been published online in ...
Other Medicine News:Health News:Drugs.com Unveils the Next Generation Medication Safety Tool to Help Consumers Avoid Dangerous Drug Interactions 2Health News:Drugs.com Unveils the Next Generation Medication Safety Tool to Help Consumers Avoid Dangerous Drug Interactions 3Health News:Drugs.com Unveils the Next Generation Medication Safety Tool to Help Consumers Avoid Dangerous Drug Interactions 4Health News:Drugs.com Unveils the Next Generation Medication Safety Tool to Help Consumers Avoid Dangerous Drug Interactions 5Health News:bWell-informed(TM) Adds Medicare Plan Tools for 2008 Open Enrollment Season 2Health News: Florida's Natural Celebrates 75 Years with Record Performance 2Health News: Florida's Natural Celebrates 75 Years with Record Performance 3Health News:World AIDS Day: Dec. 1, 2008 2Health News:TV: Not the only channel to early sex 2
... The Given system, developed by Given Imaging of ... size of a grape. Weighing in at only ... camera, 4 LED lights, battery and radio transmitter ... resistant to digestive enzymes. Internal gastric images are ...
... The catheter-free Bravo pH Monitoring ... pH testing is done. Bravo ... regular diet and activities during ... is catheter-free, the added convenience ...
... CO2 TMR technology is an ... diffuse vessels with poor targets. ... between surgical suites, the CO2 ... surgeon to make timely operative ...
... highly accurate & lightweight system utilizing state ... capacity that can take extensive measurements over ... measurement intervals from 5 to 60 minutes. ... configuration, data collection and analysis. Easy ...
Medicine Products: